The IQVIA eCOA solution is designed with a strong emphasis on patient-centricity, and the patient facing IQVIA Scribe app exemplifies this approach. Scribe streamlines the data collection process by offering an intuitive, user-friendly interface that empowers patients to easily report their health outcomes in real time, no matter what they’re doing. The app supports multiple languages and accessibility features, ensuring inclusivity across multiple patient populations. By minimizing technical barriers and integrating seamlessly with patients’ daily routines, Scribe enhances engagement and compliance, ultimately improving data quality and the overall clinical trial experience. Its offline capabilities and secure data handling further reinforce trust and convenience, making it a vital tool in modern, patient-focused research.
The IQVIA eCOA Library is a powerful resource designed to accelerate study startup and reduce complexity for sponsors by providing access to a curated collection of pre-validated, protocol-ready eCOA instruments. With standardized formats and proven configurations, sponsors can quickly identify and deploy the right assessments for their trials, minimizing customization and reducing time spent on design and validation. The library supports regulatory compliance and global scalability, ensuring consistency across studies while maintaining flexibility for specific therapeutic areas. By leveraging the eCOA Library, sponsors gain a faster, more efficient path to high-quality data collection and improved patient engagement.
Discover how a large oncology sponsor created a customized eCOA library to collect accurate, daily reported patient data across 13 countries. There was no room for error to ensure each input could ladder up into one resolution.
IQVIA eCOA enabled the sponsor to create eight new COA instruments, manage 27 languages and obtain all the necessary validations and licenses to accelerate the successful outcome of this vital oncology trial.
The IQVIA eCOA solution delivers industry-leading compliance rates, up to 95% in studies using automated data monitoring, by combining intuitive design, real-time data capture and inclusive technology. Patients can use their own devices or provisioned ones, with support for online and offline reporting, caregiver input and accessibility features like larger screens and fonts. Automated prompts and alerts keep participants engaged, while centralized updates ensure seamless mid-study changes. With the highest compliance rates and the broadest support for diverse populations, IQVIA eCOA empowers sponsors to collect cleaner data, reduce missing entries and enhance trial outcomes.
Can patients reliably complete eCOAs on their own devices?
In today’s patient-centric trials, eCOAs empower participants to share their experiences from anywhere—no clinic visit required. But as sponsors explore Bring Your Own Device (BYOD) strategies to reduce burden and boost compliance, one question looms large: will regulators approve it? Discover how IQVIA helps sponsors navigate BYOD implementation with confidence, ensuring data quality, regulatory readiness and a seamless patient experience.
IQVIA’s eCOA platform is designed to elevate the patient experience by making it easier, more intuitive and more inclusive for participants to share their treatment journeys. With secure, user-friendly apps that work across personal and provisioned devices, whether online or offline, patients can report outcomes anytime, anywhere. Automated prompts and alerts help ensure assessments are completed on time, while accessibility features like larger fonts and caregiver login options support diverse needs. By enabling real-time, high-quality data collection directly from the patient, IQVIA eCOA ensures that every voice is heard, every experience is captured and every insight drives better trial outcomes.
IQVIA eCOA configures each assessment experience to align with specific therapeutic-area requirements, including:
.svg){kind=icon}
